Wuxi city captivated hundreds of millions of viewers across China and around the world at the 2025 CMG Spring Festival Gala ...

I've lived solely in the Wuxi New District, in various locations up and down Changjiang North Road. I'd been running for a ...

Also in November, 21-year-old Xu Jiajin killed eight people and injured 17 others in a stabbing attack at his vocational ...

At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...

The companies have committed to working in close collaboration to ensure a smooth transition for employees and customers.

NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...

WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...

With a total GDP for 2024 of ¥1.626329 trillion, the average urbanite in Wuxi made ¥80,003 in 2024, an increase of 4.4 ...

WuXi AppTec sells US device testing sites to NAMSA, Notch Therapeutics cuts staff, and Neurizon's ALS drug NUZ-001 faces FDA clinical hold.

CMB International Securities analyst Jill Wu has maintained their bullish stance on WXIBF stock, giving a Buy rating on January 13.Stay Ahead ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. | The deal includes facilities in ...